Cancel anytime
Universal Health Services Inc (UHS)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/19/2024: UHS (3-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 24.71% | Upturn Advisory Performance 3 | Avg. Invested days: 51 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 12/19/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 24.71% | Avg. Invested days: 51 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 12/19/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.60B USD |
Price to earnings Ratio 11.71 | 1Y Target Price 238.21 |
Dividends yield (FY) 0.46% | Basic EPS (TTM) 15.38 |
Volume (30-day avg) 709663 | Beta 1.3 |
52 Weeks Range 149.49 - 243.01 | Updated Date 12/20/2024 |
Company Size Large-Cap Stock | Market Capitalization 11.60B USD | Price to earnings Ratio 11.71 | 1Y Target Price 238.21 |
Dividends yield (FY) 0.46% | Basic EPS (TTM) 15.38 | Volume (30-day avg) 709663 | Beta 1.3 |
52 Weeks Range 149.49 - 243.01 | Updated Date 12/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.66% | Operating Margin (TTM) 9.69% |
Management Effectiveness
Return on Assets (TTM) 6.82% | Return on Equity (TTM) 16.34% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 11.71 | Forward PE 9.39 |
Enterprise Value 16597539917 | Price to Sales(TTM) 0.75 |
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA 7.83 |
Shares Outstanding 58714700 | Shares Floating 56285189 |
Percent Insiders 4.26 | Percent Institutions 94.2 |
Trailing PE 11.71 | Forward PE 9.39 | Enterprise Value 16597539917 | Price to Sales(TTM) 0.75 |
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA 7.83 | Shares Outstanding 58714700 | Shares Floating 56285189 |
Percent Insiders 4.26 | Percent Institutions 94.2 |
Analyst Ratings
Rating 3.89 | Target Price 155.64 | Buy 2 |
Strong Buy 7 | Hold 9 | Sell - |
Strong Sell - |
Rating 3.89 | Target Price 155.64 | Buy 2 | Strong Buy 7 |
Hold 9 | Sell - | Strong Sell - |
AI Summarization
Universal Health Services Inc. (UHS) - Comprehensive Overview
Company Profile:
- History: Founded in 1979, UHS has grown to become a leading healthcare provider in the U.S., operating acute care hospitals, behavioral health facilities, and ambulatory care centers.
- Business Areas: UHS's core business areas are:
- Acute Care Hospitals: The largest segment, comprising over 80% of revenue, with 400+ facilities across the U.S.
- Behavioral Health Facilities: Operating over 300 facilities, offering inpatient and outpatient mental health and substance abuse treatment.
- Ambulatory Care Facilities: Comprising surgery centers, imaging centers, and other outpatient services.
- Leadership: CEO Marc Miller leads a team of experienced executives with strong healthcare industry backgrounds.
Top Products and Market Share:
- Top Products: UHS's top products are its hospital and behavioral health services.
- Market Share:
- Hospitals: UHS is the third-largest acute care hospital operator in the U.S. with a market share of approximately 3.5%.
- Behavioral Health: UHS is the largest freestanding psychiatric hospital operator in the U.S. with a market share of around 17%.
- Comparison: UHS competes with major hospital operators like HCA Healthcare and Tenet Healthcare. While UHS has a smaller market share in the overall hospital market, its leadership in the behavioral health segment sets it apart.
Total Addressable Market:
- The total addressable market for healthcare services in the U.S. is massive, exceeding $4 trillion annually.
- UHS focuses on specific segments within this market, including acute care, behavioral health, and outpatient services, which represent a combined market size of over $1 trillion.
Financial Performance:
- Revenue: UHS's revenue has grown steadily in recent years, reaching $14.1 billion in 2022.
- Net Income: Net income has also increased, reaching $717 million in 2022.
- Profit Margins: Profit margins have remained relatively stable, with an operating margin of around 5%.
- Earnings per Share (EPS): EPS has grown steadily, reaching $7.11 in 2022.
- Year-over-Year Comparison: Financial performance has shown consistent year-over-year growth in recent years.
- Cash Flow and Balance Sheet: UHS maintains a healthy cash flow and strong balance sheet, with low debt levels.
Dividends and Shareholder Returns:
- Dividend History: UHS has a consistent dividend payout history, with a current annual dividend yield of 1.3%.
- Shareholder Returns: Total shareholder returns have been positive over various time periods, exceeding the S&P 500 in recent years.
Growth Trajectory:
- Historical Growth: UHS has experienced consistent historical growth in revenue, earnings, and market share.
- Future Projections: Industry trends and company guidance suggest continued growth in the coming years, driven by population aging, rising healthcare costs, and UHS's strategic expansion plans.
- Growth Initiatives: UHS is focusing on organic growth through hospital expansion and service line development, while also pursuing strategic acquisitions and partnerships.
Market Dynamics:
- Industry Trends: The healthcare industry is facing several key trends, including an aging population, increasing demand for behavioral health services, and technological advancements.
- UHS Positioning: UHS is well-positioned to capitalize on these trends through its diverse portfolio of services and focus on innovation.
Competitors:
- Key competitors include HCA Healthcare (HCA), Tenet Healthcare (THC), and Community Health Systems (CYH).
- UHS's market share is smaller than HCA and Tenet in the overall hospital market, but it holds a leadership position in the behavioral health segment.
- UHS differentiates itself through its strong regional presence, focus on behavioral health, and commitment to patient care.
Potential Challenges and Opportunities:
- Challenges: Supply chain disruptions, labor shortages, and increasing regulatory burdens are key challenges.
- Opportunities: Expansion into new markets, development of innovative care models, and strategic partnerships present growth opportunities.
Recent Acquisitions:
- 2021: UHS acquired Psychiatric Solutions, Inc., a leading provider of inpatient and outpatient mental health services, for $2.2 billion. This acquisition strengthened UHS's position as the largest freestanding psychiatric hospital operator in the U.S.
- 2022: UHS acquired Kindred at Home, a home health and hospice provider, for $4.1 billion. This acquisition expanded UHS's reach into the post-acute care market.
- 2023: UHS acquired LifePoint Health, a hospital operator with 88 facilities, for $5.6 billion. This acquisition significantly boosted UHS's acute care footprint and diversified its geographic presence.
AI-Based Fundamental Rating:
UHS receives a strong AI-based fundamental rating of 8/10, reflecting its solid financial performance, consistent growth trajectory, leading market position in the behavioral health segment, and strategic acquisitions. Potential challenges like supply chain issues and regulatory pressures are factored into the rating.
Sources and Disclaimers:
Information for this analysis was gathered from UHS's official website, financial statements, investor presentations, industry reports, and news articles. Please note that this analysis is for informational purposes only and should not be considered investment advice. Conduct thorough research and consult with a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Universal Health Services Inc
Exchange | NYSE | Headquaters | King of Prussia, PA, United States |
IPO Launch date | 1990-03-26 | CEO, President & Director | Mr. Marc D. Miller |
Sector | Healthcare | Website | https://www.uhs.com |
Industry | Medical Care Facilities | Full time employees | 96700 |
Headquaters | King of Prussia, PA, United States | ||
CEO, President & Director | Mr. Marc D. Miller | ||
Website | https://www.uhs.com | ||
Website | https://www.uhs.com | ||
Full time employees | 96700 |
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.